Viking Therapeutics (VKTX) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free VKTX Stock Alerts $62.26 +0.48 (+0.78%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 1:18 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Rating Increased to Sell at StockNews.comStockNews.com raised shares of Viking Therapeutics to a "sell" rating in a research note on Friday.May 30 at 4:03 PM | prnewswire.comViking Therapeutics to Participate at Upcoming Investor ConferencesMay 29 at 6:30 AM | investorplace.comIf You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 NamesMay 27, 2024 | msn.comSA Asks: Who will launch the next big weight-loss drug?May 27, 2024 | americanbankingnews.comViking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Recommendation of "Buy" from BrokeragesMay 27, 2024 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Rating of "Buy" from AnalystsViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) has been assigned a consensus rating of "Buy" from the ten ratings firms that are currently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to tMay 26, 2024 | fool.comIf You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have TodayMay 25, 2024 | msn.comViking, CRISPR, Intellia among potential M&A targets: Wells FargoMay 25, 2024 | investorplace.com3 Biotech Stocks That Could Be Millionaire-Makers: May EditionMay 25, 2024 | fool.comWhere Will Viking Therapeutics Be in 5 Years?May 24, 2024 | fool.com2 Stocks That Could 10x by 2035May 23, 2024 | investorplace.comDip Then Rip? 3 Nasdaq Stocks to Buy Before the ReboundMay 22, 2024 | fool.comIs It Too Late to Buy Viking Therapeutics Stock?May 22, 2024 | marketbeat.comSwiss National Bank Sells 29,900 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Swiss National Bank cut its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 15.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 167,600 shares of the biotechnology company's stock after selling 29,900 sharesMay 21, 2024 | investorplace.com3 Growth Stocks That Could Be Millionaire-Makers: May EditionMay 21, 2024 | marketbeat.comLevel Four Advisory Services LLC Increases Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Level Four Advisory Services LLC grew its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 87.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 31,374 shares of the biotechnology company's stock after buying an additional 14,638 shareMay 20, 2024 | investorplace.comWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024May 19, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Makes New $12.34 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Massachusetts Financial Services Co. MA acquired a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 663,May 18, 2024 | fool.com3 Monster Stocks in the Making You Can Buy Right NowMay 17, 2024 | investorplace.comPharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?May 17, 2024 | msn.comRaymond James Upgrades Viking Therapeutics (VKTX)May 17, 2024 | baystreet.caStock Sell Alerts: Cisco Systems, Viking Therapeutics, B. RileyMay 17, 2024 | fool.comIs Viking Therapeutics Stock a Buy?May 16, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Down to $78.01Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down to $78.01May 16, 2024 | msn.comViking falls after Roche’s obesity drug data; RayJay upgrades (update)May 16, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Raised to "Strong-Buy" at Raymond JamesRaymond James raised Viking Therapeutics from an "outperform" rating to a "strong-buy" rating and increased their price target for the company from $115.00 to $116.00 in a report on Thursday.May 16, 2024 | marketbeat.comViking Therapeutics' (VKTX) Buy Rating Reaffirmed at Truist FinancialTruist Financial reaffirmed a "buy" rating and issued a $120.00 price objective on shares of Viking Therapeutics in a research note on Thursday.May 16, 2024 | investorplace.comTiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000May 15, 2024 | benzinga.comHere's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth TodayMay 14, 2024 | investorplace.comDouble-Up Delights: 7 Stocks Poised to Soar 100% by 2025May 13, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 3.4% Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 3.4%May 13, 2024 | finance.yahoo.comIs Viking Therapeutics the Best Biotech Stock for You?May 13, 2024 | fool.comHow Viking Therapeutics Stock Could 30xMay 11, 2024 | marketbeat.comRussell Investments Group Ltd. Makes New $4.78 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Russell Investments Group Ltd. bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 256,633 shares of the biotechnology company's sMay 10, 2024 | investorplace.comThe 3 Best Russell 2000 Stocks to Buy in May 2024May 7, 2024 | investorplace.comBiotech Breakthroughs: 7 Stocks Driving the Next Wave in HealthcareMay 7, 2024 | cnbc.comAmgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceMay 6, 2024 | marketbeat.comLisanti Capital Growth LLC Makes New $6.49 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Lisanti Capital Growth LLC acquired a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 348,970 shares of the biMay 6, 2024 | finance.yahoo.comViking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the companyMay 6, 2024 | marketbeat.comEli Lilly Gains on the GLP-1 Weight Loss Phenomenon (VKTX)Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugsMay 4, 2024 | insidertrades.comInsider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells 66,756 Shares of StockMay 3, 2024 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) CFO Greg Zante Sells 66,756 SharesViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) CFO Greg Zante sold 66,756 shares of the firm's stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $74.69, for a total value of $4,986,005.64. Following the transaction, the chief financial officer now directly owns 174,854 shares of the company's stock, valued at $13,059,845.26. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 3, 2024 | insidertrades.comViking Therapeutics, Inc. (NASDAQ:VKTX) COO Marianna Mancini Sells 281,425 SharesMay 2, 2024 | investorplace.comWhat Is the Best Weight Loss Stock to Buy Now? Our Top 3 PicksMay 2, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 2.1% Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.1%May 2, 2024 | marketbeat.comJFG Wealth Management LLC Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)JFG Wealth Management LLC purchased a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,000 shares of the biotechnology company's sMay 1, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Down 4%Viking Therapeutics (NASDAQ:VKTX) Shares Down 4%May 1, 2024 | benzinga.comHere's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 YearsMay 1, 2024 | investorplace.comStock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices PlungeApril 30, 2024 | fool.comViking Therapeutics Delivers Smaller-Than-Expected Q1 Loss Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. VKTX Media Mentions By Week VKTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.840.81▲Average Medical News Sentiment VKTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼117▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Prothena News Today Puma Biotechnology News Today Marinus Pharmaceuticals News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Royalty Pharma News Today BeiGene News Today BioMarin Pharmaceutical News Today Viatris News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyOn June 10, Nvidia makes its next big moveWeiss RatingsUnlock Explosive Gains with This Defense StockBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe Worst is Yet to Come…Porter & CompanyDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
